SG11201806122YA - Proteinaceous compounds and uses therefor - Google Patents
Proteinaceous compounds and uses thereforInfo
- Publication number
- SG11201806122YA SG11201806122YA SG11201806122YA SG11201806122YA SG11201806122YA SG 11201806122Y A SG11201806122Y A SG 11201806122YA SG 11201806122Y A SG11201806122Y A SG 11201806122YA SG 11201806122Y A SG11201806122Y A SG 11201806122YA SG 11201806122Y A SG11201806122Y A SG 11201806122YA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- pct
- pkc
- english
- february
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000009028 cell transition Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 abstract 1
- 238000005755 formation reaction Methods 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 230000002018 overexpression Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 102220240796 rs553605556 Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/11—Protein-serine/threonine kinases (2.7.11)
- C12Y207/11013—Protein kinase C (2.7.11.13)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016900314A AU2016900314A0 (en) | 2016-02-01 | Proteinaceous compounds and uses therefor | |
| PCT/AU2017/050083 WO2017132728A1 (en) | 2016-02-01 | 2017-02-01 | Proteinaceous compounds and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201806122YA true SG11201806122YA (en) | 2018-08-30 |
Family
ID=59499146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201806122YA SG11201806122YA (en) | 2016-02-01 | 2017-02-01 | Proteinaceous compounds and uses therefor |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10487115B2 (https=) |
| EP (1) | EP3411061A4 (https=) |
| JP (2) | JP7341451B2 (https=) |
| CN (2) | CN108883155A (https=) |
| AU (1) | AU2017214761B2 (https=) |
| CA (1) | CA3011870A1 (https=) |
| SG (1) | SG11201806122YA (https=) |
| WO (1) | WO2017132728A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019090390A1 (en) * | 2017-11-08 | 2019-05-16 | University Of Canberra | Immunogenic compositions and uses therefor |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4873192A (en) | 1987-02-17 | 1989-10-10 | The United States Of America As Represented By The Department Of Health And Human Services | Process for site specific mutagenesis without phenotypic selection |
| ATE285477T1 (de) | 1995-06-07 | 2005-01-15 | Inex Pharmaceutical Corp | Herstellung von lipid-nukleinsäure partikeln duch ein hydrophobische lipid-nukleinsäuree komplexe zwischenprodukt und zur verwendung in der gentransfer |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| BR9707495A (pt) | 1996-02-13 | 1999-07-27 | Zeneca Ltd | Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente |
| US6291455B1 (en) | 1996-03-05 | 2001-09-18 | Zeneca Limited | 4-anilinoquinazoline derivatives |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| EP1002091B1 (en) | 1997-07-09 | 2012-02-29 | Coridon Pty Limited | Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| AUPP807899A0 (en) | 1999-01-08 | 1999-02-04 | University Of Queensland, The | Codon utilization |
| WO2000036083A2 (en) * | 1998-12-17 | 2000-06-22 | La Jolla Institute For Allergy And Immunology | Pkc-interacting cousin of trx (picot) polypeptides, polynucleotides, and methods of making and using them |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| NZ522074A (en) | 2000-05-31 | 2004-06-25 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| CN1255392C (zh) | 2000-07-07 | 2006-05-10 | 安吉奥金尼药品有限公司 | 作为血管生成抑制剂的秋水仙醇衍生物 |
| IL153484A0 (en) | 2000-07-07 | 2003-07-06 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors |
| CA2405728A1 (en) | 2000-07-31 | 2002-02-07 | Dabur Research Foundation | Lipid-peptide conjugates for treatment of cancer |
| AU2003236720A1 (en) | 2002-06-14 | 2003-12-31 | Altana Pharma Ag | Substituted diaminopyrimidines |
| WO2004076654A1 (en) * | 2003-02-28 | 2004-09-10 | Novartis Ag | Three-dimensional structure of the catalytic domain of protein c theta, methods and use thereof |
| CA2604243C (en) | 2004-04-14 | 2015-11-24 | Avirid, Inc. | Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases |
| KR100859972B1 (ko) | 2006-02-20 | 2008-09-25 | 이화여자대학교 산학협력단 | 막투과 단백질 도메인 펩타이드 |
| BR112013010926A2 (pt) * | 2010-11-01 | 2016-08-23 | Univ Technology Sidney | agentes imunomoduladores e seus usos |
| DK2683419T3 (en) * | 2011-03-11 | 2018-07-02 | Vib Vzw | Molecules and Methods for Inhibition and Detection of Proteins |
| AU2013323101C1 (en) | 2012-09-27 | 2021-08-19 | University Of British Columbia | Peptide directed protein knockdown |
| EP3046560B1 (en) | 2013-09-18 | 2021-01-06 | EpiAxis Therapeutics Pty Ltd | Stem cell modulation ii |
| CA2958704A1 (en) | 2014-08-25 | 2016-03-03 | University Of Canberra | Compositions for modulating cancer stem cells and uses therefor |
-
2017
- 2017-02-01 JP JP2018539984A patent/JP7341451B2/ja active Active
- 2017-02-01 CN CN201780021694.9A patent/CN108883155A/zh active Pending
- 2017-02-01 AU AU2017214761A patent/AU2017214761B2/en active Active
- 2017-02-01 US US16/074,690 patent/US10487115B2/en active Active
- 2017-02-01 CN CN202211550292.7A patent/CN116082457A/zh active Pending
- 2017-02-01 SG SG11201806122YA patent/SG11201806122YA/en unknown
- 2017-02-01 CA CA3011870A patent/CA3011870A1/en not_active Abandoned
- 2017-02-01 EP EP17746642.2A patent/EP3411061A4/en active Pending
- 2017-02-01 WO PCT/AU2017/050083 patent/WO2017132728A1/en not_active Ceased
-
2021
- 2021-10-29 JP JP2021178010A patent/JP2022023949A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019506167A (ja) | 2019-03-07 |
| JP2022023949A (ja) | 2022-02-08 |
| WO2017132728A1 (en) | 2017-08-10 |
| AU2017214761B2 (en) | 2024-02-01 |
| JP7341451B2 (ja) | 2023-09-11 |
| AU2017214761A1 (en) | 2018-08-02 |
| EP3411061A4 (en) | 2019-07-10 |
| CN116082457A (zh) | 2023-05-09 |
| EP3411061A1 (en) | 2018-12-12 |
| US10487115B2 (en) | 2019-11-26 |
| US20190040103A1 (en) | 2019-02-07 |
| CN108883155A (zh) | 2018-11-23 |
| CA3011870A1 (en) | 2017-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201909432SA (en) | Compounds for increasing genome editing efficiency | |
| SG11201808476SA (en) | Recycling of polymer matrix composite | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201808990QA (en) | Compositions for topical application of compounds | |
| SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
| SG11201908820VA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201909011PA (en) | Niraparib compositions | |
| SG11201901624RA (en) | Lysine specific histone demethylase-1 inhibitors and uses therefor | |
| SG11201806624XA (en) | Deposition of molybdenum thin films using a molybdenum carbonyl precursor | |
| SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201900743UA (en) | Multiple function exercise device | |
| SG11201806544XA (en) | Compounds and methods of treating rna-mediated diseases | |
| SG11201803918VA (en) | Production of steviol glycosides in recombinant hosts | |
| SG11201804704PA (en) | Compositions and methods for decreasing tau expression | |
| SG11201904535VA (en) | Prevention and treatment of bone and cartilage damage or disease | |
| SG11201903153PA (en) | Metal recovery process | |
| SG11201810975UA (en) | Method for stabilizing proteins | |
| SG11201807949WA (en) | Engineered immunoglobulins with altered fcrn binding | |
| SG11201900883UA (en) | Combination treatment for hematological cancers | |
| SG11201805149XA (en) | Compositions comprising 15-hepe and methods of using the same | |
| SG11201805191SA (en) | Yeast cell | |
| SG11201806133UA (en) | Intermediates in the synthesis of eribulin and related methods of synthesis | |
| SG11201903061YA (en) | Combination treatments comprising administration of imidazopyrazinones | |
| SG11201406927VA (en) | Electrolytic cell equipped with concentric electrode pairs | |
| SG11201909837YA (en) | Methods for treating lung disorders |